Genetic Contributions to Recovery following Brain Trauma: A Narrative Review

Area of Science:

• Neuroscience
• Genetics
• Immunology

Background:

• Traumatic brain injury (TBI) presents variable patient recovery despite medical advances.
• Individual genetic factors are increasingly recognized as key determinants of TBI outcomes.
• Understanding genetic influences is crucial for personalized TBI treatment strategies.

Purpose of the Study:

• To review the role of genetic factors in TBI pathophysiology and recovery.
• To highlight specific genetic mechanisms including cytokine polymorphisms, mtDNA haplotypes, and immune cell genetics.
• To explore the potential of gene therapy for improving TBI outcomes.

Main Methods:

• Literature review focusing on genetic influences in TBI.
• Analysis of research on cytokine gene polymorphisms (e.g., IL-1β, TNF-α).
• Examination of mitochondrial DNA (mtDNA) haplotypes and their association with TBI recovery.
• Review of immune cell genetics and gene therapy applications in TBI models.

Main Results:

• Specific cytokine polymorphisms are linked to poor TBI outcomes (disability, death).
• Certain mtDNA haplotypes (K, T, J) show protective effects, while others (H) are associated with slower recovery.
• Immune cell genetics present both detrimental and beneficial roles in TBI recovery.
• Gene therapy demonstrates promise in enhancing cognitive and neuromotor functions post-TBI.

Conclusions:

• Genetic factors play a significant role in modulating TBI recovery.
• Cytokine polymorphisms and mtDNA haplotypes are critical determinants of TBI prognosis.
• Gene therapy offers a promising avenue for future TBI treatment development.
• Further research, particularly clinical translation, is needed to leverage genetic insights for TBI patient care.